New treatment could cure blindness in some

Woman's eye from Shutterstock
Woman's eye from Shutterstock

People who have suffered eye injuries caused by solvents, acids, abrasive and chemical agents will have new treatment available.

Europe has approved the Western world's first medicine containing stem cells to treat a rare condition caused by burns to the eye, marking a milestone in the use of the technology.

Holoclar, from privately held Italian company Chiesi, was given a marketing green light on Friday by the European Commission for treating so-called limbal stem cell deficiency due to physical or chemical burns. Left untreated, the condition can result in blindness.

The stem-cell therapy is a living-tissue product. It resembles a contact lens and is made from a biopsy taken from a small undamaged area of a patient's cornea and grown in the laboratory using cell culture.

The conditional marketing authorisation had been expected, following a positive recommendation by the European Medicines Agency in December.

Chiesi said the approval meant that Holoclar would be available "in the near future" to all suitable patients in Europe, including people who have suffered eye injuries caused by solvents, acids, abrasive and chemical agents".

Also read:

What are those things floating in your eye?

Protect your eyes from harmful UV rays

Child who can see in the dark

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24